UBS Lowers Estimates on Cadence Pharma (CADX); Ofirmev’s Sales Remain Disappointing
Go back to UBS Lowers Estimates on Cadence Pharma (CADX); Ofirmev’s Sales Remain Disappointing| Cadence Pharmaceuticals, Inc. (NASDAQ: CADX) | Delayed: 13.98 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.98 | 52 Week High | $11.92 | |||
| Open | $13.98 | 52 Week Low | $4.45 | |||
| Day High | $13.98 | P/E | N/A | |||
| Day Low | $13.98 | EPS | $-0.49 | |||
| Volume | 282,940 | |||||
